Fecal Microbiota and Volatile Metabolome Pattern Alterations Precede Late-Onset Meningitis in Preterm Neonates
Clinical Scorecard: Changes in Fecal Microbiota and Volatile Metabolome Patterns May Indicate Late-Onset Meningitis in Preterm Infants
At a Glance
Category Detail
Condition Late-onset neonatal meningitis (LOM) in preterm infants Key Mechanisms Alterations in fecal microbiota composition and volatile metabolome precede LOM; bacterial translocation from gut to CSF via bloodstream Target Population Preterm infants born before 30 weeks’ gestation Care Setting Neonatal intensive care units (NICUs)
Key Highlights
LOM has ~25% mortality and 24%-58% long-term neurological sequelae among survivors. Fecal microbiota composition can predict LOM 1–3 days before diagnosis with high accuracy (AUC 0.88). Volatile metabolome alterations moderately associate with preclinical LOM (AUC 0.70–0.76), but no single discriminative metabolites identified. Guideline-Based Recommendations
Diagnosis
Current gold standard is cerebrospinal fluid (CSF) culture, though lumbar puncture can be challenging or contraindicated. CSF biochemical parameters (WBC count, protein, glucose) aid diagnosis but are often difficult to interpret in preterm infants. Consider fecal microbiota analysis as a potential noninvasive early biomarker for LOM. Management
Empiric high-dose broad-spectrum antibiotics should be initiated promptly upon clinical suspicion of LOM. Treatment duration typically ≥7 days based on clinical and laboratory findings. Monitoring & Follow-up
Monitor clinical signs of infection (temperature instability, apnea, bradycardia, irritability/lethargy). Regular assessment of CSF parameters and blood cultures as feasible. Consider longitudinal fecal sampling for microbiota and metabolome changes in research or specialized settings. Risks
Delayed diagnosis increases risk of mortality and neurological sequelae. Lumbar puncture may be contraindicated in hemodynamically unstable or thrombocytopenic infants. Empiric antibiotic use may complicate future CSF culture interpretation. Patient & Prescribing Data
Preterm infants (<30 weeks gestation) with suspected or confirmed LOM
Empiric broad-spectrum antibiotics initiated based on clinical suspicion; early diagnosis may improve targeted therapy and outcomes.
Clinical Best Practices
Use matched controls and longitudinal fecal sampling to identify early microbiota changes preceding LOM. Employ 16S rRNA sequencing and GC-IMS for fecal microbiota and volatile metabolome analysis respectively. Integrate microbiota pattern recognition models to support early LOM diagnosis. Recognize limitations of CSF culture and biochemical markers in preterm infants and consider adjunctive noninvasive biomarkers. Prompt initiation of antibiotic therapy upon clinical suspicion to reduce adverse outcomes. References
